Anzeige
Mehr »
Login
Montag, 16.05.2022 Börsentäglich über 12.000 News von 666 internationalen Medien
InnoCan Pharma - Bewegende News ante portas?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CYE9 ISIN: US2498451085 Ticker-Symbol:  
NASDAQ
16.05.22
19:23 Uhr
0,760 US-Dollar
-0,030
-3,85 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
DERMATA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
DERMATA THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur DERMATA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.04.Dharma Polimetal channels extra IDR 20 billion to its subsidiary: PT Dharma Polimetal Tbk (DRMA), a ...1
25.04.Dermata Therapeutics Announces Closing of $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules178SAN DIEGO, CA / ACCESSWIRE / April 25, 2022 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA) (NASDAQ:DRMAW), a clinical-stage biotechnology company focusing on the treatment...
► Artikel lesen
25.04.Dermata Therapeutics, Inc. - 8-K, Current Report1
DERMATA THERAPEUTICS Aktie jetzt für 0€ handeln
21.04.Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules216SAN DIEGO, CA / ACCESSWIRE / April 21, 2022 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA) and (NASDAQ:DRMAW), a clinical-stage biotechnology company focusing on the treatment...
► Artikel lesen
28.03.Dermata Therapeutics GAAP EPS of -$2.43 beats by $0.75-
28.03.Dermata Therapeutics, Inc. - 8-K, Current Report-
28.03.Dermata Therapeutics, Inc. - 10-K, Annual Report-
28.03.Dermata Therapeutics Provides Corporate Update and Reports Full Year 2021 Financial Results224DMT310 Phase 2 rosacea trial is over two-thirds enrolled with topline results expected in H2 2022DMT310 Phase 2 psoriasis trial to start H1 2022, with topline results expected in H1 2023DMT310 Phase...
► Artikel lesen
28.03.Expanding its business, DRMA allocates IDR 353 billion as CapEx: PT Dharma Polimetal Tbbk (DRMA) allocates ...2
24.03.Dermata Therapeutics to Participate in the 2022 Maxim Group Virtual Growth Conference135SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic...
► Artikel lesen
18.03.DRMA net profit jumps 37 folds in 2021: PT Dharma Polimetal Tbk. (DRMA), a listed automotive component ...3
02.03.Dermata Therapeutics, Inc. - 8-K, Current Report1
25.02.Eyeing double-digit growth, DRMA builds a factory and buys machines: The directors of PT Dharma Polimetal ...1
24.02.DRMA boosts production while maintaining employee's health: PT Dharma Polimetal Tbk (DRMA), a listed ...1
11.02.DRMA showcases electric battery and electric bike at JCC: PT Dharma Polimetal Tbk. (";DRMA"), a listed ...3
10.02.Dermata, Innoviva top healthcare gainers; while InfuSystem, Seagen lead losers pack7
10.02.DRMA, GRAB and SLI among pre market gainers6
10.02.Pre-market Movers: DRMA, TWOU, NDRA, USX, VMEO.405BURBANK (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.30 A.M. ET).In the Green Dermata Therapeutics, Inc. (DRMA) is up over 35%...
► Artikel lesen
07.02.Dermata Therapeutics, Inc. - S-1/A, General form for registration of securities1
07.02.IceCure Medical, Atossa top healthcare gainers; Dermata, Statera among losers23
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1